Beijing Beilu Pharmaceutical Co., Ltd was established in September 1992.The company is mainly engaged in the research & development, production and sales of pharmaceutical products. It is a national high-tech enterprise, one of the first batch of listed enterprises in Growth Enterprises Market (stock code 300016), and a leading contrast agent enterprise .
Beilu is the first company to develop and launch the contrast agent products in China, filling the gap in domestic market, and forming a unique core competitive advantage in this field is the market leader in the domestic contrast agent industry. In addition, the company has also strengthened R&D in the field of psychoneurosis and endocrinology drugs, and strive to achieve variety diversification.
The company’s Miyun pharmaceutical factory has built the contrast agent production line designed according to the EU standards. The workshop adopts international advanced equipment and design concepts to ensure the product quality in line with international standards. Meanwhile, to implement the national strategy of integration development of the Beijing-Tianjin-Hebei region, the company has built traditional Chinese medicine extraction and API production base in Cangzhou Bohai New Area, to achieve the layout of the industry chain in Beijing and Cangzhou.
In the future, the company will continue to consolidate its leading position in the contrast agent market, strive to build corporate brand, achieve product diversification, and create long-term and sustainable value growth and performance returns for customers and investors.